Pure red cell aplasia associated with expansion of CD3+ CD8 + granular lymphocytes expressing cytotoxicity against HLA-E + cells

British Journal of Haematology

Volumn 123, Issue 1, 2003, Pages 147-153

  Mori, Kiyoshi L ^a   Furukawa, Hisae ^a   Hayashi, Keiko ^a   Sugimoto, Kei Ji J ^a   Oshimi, Kazuo ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

CD94; HLA E; Killer immunoglobulin like receptors; Pure red cell aplasia; T cell granular lymphocyte proliferative disorder

Indexed keywords

CD94 ANTIGEN; HLA E ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CELL ISOLATION; CELL STIMULATION; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; ERYTHROCYTE APLASIA; HUMAN; LARGE GRANULAR LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; TROPHOBLAST;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD94; CELL DEATH; CELL LINE; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; LECTINS, C-TYPE; LEUKEMIA, T-CELL, ACUTE; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RED-CELL APLASIA, PURE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0141818960     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04553.x     Document Type: Article

References (32)

1. + T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody. Journal of Immunology, 144, 3238-3247.
2. Borrego, F., Ulbrecht, M., Weiss, E.H., Coligan, J.E. & Brooks, A.G. (1998) Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. Journal of Experimental Medicine, 817, 813-818.
3. Braud, V.M., Allan, D.S.J., O'Callaghan, C.A., Soderstorom, K., D'Andrea, A., Ogg, G.S., Lazetic, S., Young, N.T., Bell, J.I., Phillips, J.H. & Lanier, L.L. (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature, 391, 795-799.
4. Carosella, E.D., Dausset, J. & Kirszenbaum, M. (1996) HLA-G revisited. Immunology Today, 17, 407-409.
5. Casado, L.F., Granados, E., Algara, P., Navarro, F., Martinez-Frejo, M. & Lopez-Botet, M. (2001) High expression of the ILT2 (LIR-1) inhibitory receptor for major histocompatibility complex class I molecules on clonal expansions of T-large granular lymphocytes in asymptomatic patients. Haematologica, 86, 457-463.
6. Chang, C., Rodriguez, A., Carretero, M., Lopez-Botet, M., Philips, J.H. & Lanier, L.L. (1995) Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. European Journal of Immunology, 25, 2433-2437.
7. Ellis, S.A., Palmer, M.S. & McMichael, A.J. (1990) Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule. Journal of Immunology, 144, 731-735.
8. Exley, M., Porcelli, S., Furman, M., Garcia, J. & Balk, S. (1998) CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant Vα24 JαQ T cell receptor α chains. Journal of Experimental Medicine, 188, 867-876.
9. Fisch, P., Handgretinger, R. & Schaefer, H.-E. (2000) Pure red cell aplasia. British Journal of Haematology, 111, 1010-1022.
10. Frohn, C., Shlenke, P. & Kirchner, H. (1997) The repertoire of HLA-Cw-specific NK cell receptors CD158a/b (EB6 and GL183) in individuals with different HLA phenotype. Immunology, 92, 567-570.
11. Haedicke, W., Ho, F.C., Chott, A., Moretta, I., Rudiger, T., Ott, G. & Muller-Hermilink, H.K. (2000) Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas. Blood, 95, 3628-3630.
12. Handgretinger, R., Geiselhart, A., Moris, A., Grau, R., Teuffel, O., Bethge, W., Kanz, L. & Fisch, P. (1999) Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expression killer-cell inhibitory receptors. New England Journal of Medicine, 340, 278-284.
13. Hoffman, R., Kopel, S., Hsu, S.D., Dainiak, N. & Zanjani, E.D. (1978) T cell chronic lymphocytic leukemia: presence in bone marrow and peripheral blood of cells that suppress erythropoiesis in vitro. Blood, 52, 255-260.
14. Karre, K., Liunggren, G.H., Piontek, G. & Kiessling, R. (1986) Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defence strategy. Nature, 319, 675-678.
15. King, A., Allan, S.J.D., Bowen, M., Powis, S.J., Joseph, S., Verma, S., Hiby, S.E., McMichael, A.J., Loke, Y.W. & Braud, V.M. (2000) HLA-E is expressed on trophoblast and interacts with CD94/NKG2 on decidual NK cells. European Journal of Immunology, 30, 1623-1631.
16. Lanier, L.L. (1998) Follow the leader: NK cell receptor classical and non-classical MHC class I. Cell, 92, 705-707.
17. Lanier, L.L., Corliss, B.C., Wu, J., Leong, C. & Phillips, J.H. (1998) Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature, 391, 703-707.
18. Lee, N., Goodlett, D.E., Ishitani, A., Marquardt, H. & Geraghty, D.E. (1998) HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. Journal of Immunology, 160, 4951-4960.
19. Long, E.O. (1999) Regulation of immune responses through inhibitory receptors. Annual Review of Immunology, 17, 875-904.
20. Masmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 55-63.
21. Moretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M.C. & Moretta, L. (1997) Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunological Review, 155, 105-107.
22. Mori, K.L., Egashira, M. & Oshimi, K. (2001) Differentiation stage of natural killer cell-lineage lymphoproliferative disorders based on phenotypic analysis. British Journal of Haematology, 115, 225-228.
23. Oshimi, K. (1996) Lymphoproliferative disorders of natural killer cells. International Journal of Hematology, 63, 279-290.
24. Oshimi, K., Yamada, O., Kaneko, T., Nishinarita, S., Iizuka, Y., Urabe, A., Inamori, T., Asano, S., Takahashi, S., Hattori, M., Naohara, T., Ohira, Y., Togawa, A., Masuda, Y., Okubo, Y., Furukawa, S., Sakamoto, S., Omine, M., Mori, M., Tatsumi, E. & Mizoguchi, H. (1993) Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia, 7, 782-788.
25. Pazmany, L., Mandelboim, O., Vales-Gomez, M., Davis, D.M., Reyburn, H.T. & Strominger, J.L. (1996) Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science, 274, 792-795.
26. Perez-Villar, J.J., Carretero, M., Navarro, F., Melero, I., Rodriguez, A., Bottino, C., Moretta, A. & Lopez-Botet, M. (1996) Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor. Journal of Immunology, 157, 5367-5374.
27. Ryan, J.C., Naper, C., Hayashi, S. & Daws, M.R. (2001) Physiologic functions of activating natural killer (NK) complex-encoded receptors on NK cells. Immunological Review, 181, 126-135.
28. Semenzat, G., Zambello, R., Starkebaum, G., Oshimi, K. & Loughran, Jr, T.P. (1997) The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood, 89, 256-260.
29. Spits, H., Blom, B., Jaleco, A.C., Weijer, K., Verschuren, M.C., van Donge, J.J., Heemskerk, M.H. & Res, P.C. (1998) Early stages in the development of human T, natural killer and thymic dendritic cells. Immunological Review, 165, 75-86.
30. Tefferi, A. (1996) Chronic natural killer cell lymphocytosis. Leukemia and Lymphoma, 20, 245-248.
31. Ugolini, S. & Vivier, E. (2000) Regulation of T cell function by NK cell receptors for classical MHC class I molecules. Current Opinions in Immunology, 12, 295-300.
32. Voss, S.D., Daley, J., Ritz, J. & Robertson, M.J. (1998) Participation of the CD94 receptor complex in costimulation of human natural killer cells. Journal of Immunology, 160, 1618-1626.